Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Risler

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Transplantation Proceedings|February 1, 1987
Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprineW D Schareck, U T Hopt, G H Müller, et al.
Journal of Clinical Apheresis|January 1, 1991
Application of a new LDL apheresis system using two dextran sulfate cellulose columns in combination with an automatic column-regenerating unit and a blood cell separatorW Knisel, M Müller, I Besenthal, et al.
Experimental Nephrology|September 1, 1995
Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesisC M Erley, S Rebmann, U Strobel, et al.
Nephron|January 1, 1991
Detection of human cytomegalovirus-DNA in IgA nephropathyG A Müller, W Kühn, C A Müller, et al.
Journal of Internal Medicine|November 1, 1993
Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systemsW Knisel, A Di Nicuolo, M Pfohl, et al.
Cardiovascular Drugs and Therapy|April 1, 1989
Low-dose enalapril in severe chronic heart failureC G Brilla, B Krämer, H M Hoffmeister, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Digoxon or digitoxin in patients with terminal kidney insufficiency in the dialysis stage?]T Risler, U Peters, B Grabensee, et al.
Clinical Nephrology|April 24, 2003
Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patientsS C Wolf, O Mayer, S Jürgens, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Renal effects of the new calcium channel blocking drug isradipineB K Krämer, M Häussler, K M Ress, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Endothelin-receptor antagonists in uremic cardiomyopathyS C Wolf, F Gaschler, S Brehm, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Transplantation Proceedings|February 1, 1987
Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprineW D Schareck, U T Hopt, G H Müller, et al.
Journal of Clinical Apheresis|January 1, 1991
Application of a new LDL apheresis system using two dextran sulfate cellulose columns in combination with an automatic column-regenerating unit and a blood cell separatorW Knisel, M Müller, I Besenthal, et al.
Experimental Nephrology|September 1, 1995
Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesisC M Erley, S Rebmann, U Strobel, et al.
Nephron|January 1, 1991
Detection of human cytomegalovirus-DNA in IgA nephropathyG A Müller, W Kühn, C A Müller, et al.
Journal of Internal Medicine|November 1, 1993
Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systemsW Knisel, A Di Nicuolo, M Pfohl, et al.
Cardiovascular Drugs and Therapy|April 1, 1989
Low-dose enalapril in severe chronic heart failureC G Brilla, B Krämer, H M Hoffmeister, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Digoxon or digitoxin in patients with terminal kidney insufficiency in the dialysis stage?]T Risler, U Peters, B Grabensee, et al.
Clinical Nephrology|April 24, 2003
Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patientsS C Wolf, O Mayer, S Jürgens, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Renal effects of the new calcium channel blocking drug isradipineB K Krämer, M Häussler, K M Ress, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Endothelin-receptor antagonists in uremic cardiomyopathyS C Wolf, F Gaschler, S Brehm, et al.
Pageof 16